Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-29T05:38:46.220Z Has data issue: false hasContentIssue false

CS03-03 - Treatment of Depression and Diabetes when Co-Morbid

Published online by Cambridge University Press:  17 April 2020

C. van der Feltz-Cornelis*
Affiliation:
Research Program: Diagnosis and Treatment of Common Mental Disorders, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands Psychiatry Department, VU University Medical Center, Amsterdam, The Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In this lecture, an overview will be given of the literature concerning treatment for comorbid diabetes and depression. A systematic review and analysis will be presented. It turns out that, although many clinicians and researchers find this an important subject of research, and although the clinical implications of such research seem obvious, randomized clinical trials evaluating effectiveness of treatment are scarce and often the numbers of patients included are small. However, all RCTs point in the direction of efficacy of treatment of this combined condition in terms of combined impact. Severity of depressive symptoms and glycemic control are most often used as outcome measures. Psychotherapeutic interventions show a moderate to large effect on both ; antidepressant treatment as well as collaborative care show moderate effects on depressive symptom severity. The clinical, public health and research implications of these findings will be discussed.

Type
Co-morbidity of diabetes and depression: problems for science and consequences for parctice
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.